Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIvoraxaban Safety and Efficacy in Patients With Mitral Stenosis

NCT03926156 is registered in ClinicalTrials.gov with Rajaie Cardiovascular Medical and Research Center as lead sponsor.

NCT NCT03926156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03926156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIvoraxaban Safety and Efficacy in Patients With Mitral Stenosis
Lead sponsor
Rajaie Cardiovascular Medical and Research Center
Phase
Phase 3
Overall status
Terminated
Start date
May 22, 2019
Completion date
August 14, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant adverse reaction, atrial fibrillation, mitral stenosis, rheumatic heart disease